Board/Management Information • Jun 3, 2024
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 7499Q
Pets At Home Group Plc
03 June 2024
FOR IMMEDIATE RELEASE 3 June 2024
Pets at Home Group plc, the UK's leading pet care business, announces a change to its Board of Directors with the appointment of a new independent Non-Executive Director.
Garret Turley will be appointed as an independent Non-Executive Director with effect from 12 July 2024.
On appointment to the Board, Garret will also become a member of the Nomination and Corporate Governance Committee and will chair the ESG Committee.
Garret is a qualified veterinarian who co-founded and built Pet Doctors, after which he transitioned into private equity at Bridges Ventures where his focus was on health and education investments. Garret then joined August Equity as a Partner, where his role focused on the healthcare, social care and education sectors through strategic investments. Garret has significant board experience and currently chairs a privately owned social care business Koala Care, is a Non- Executive Director at Dunrogan on a family office board in his native Northern Ireland and chairs Blackrose, a boutique corporate advisory house.
Ian Burke, Chair of Pets at Home, commented :
"On behalf of the Board, I am delighted to welcome Garret Turley to Pets at Home Group plc. Garret has excellent experience in the veterinary sector and will bring strong strategic knowledge in this area, which continues to be a key part of the group's strategy. The directors and I look forward to Garret joining in July."
This disclosure is given in accordance with Listing Rule 9.6.11.
Enquiries
Pets at Home Group Plc:
Lesley Lazenby, Company Secretary
+44 (0)161 468 6688
Pets at Home Group Plc:
Andrew Porteous, Director of Investor Relations
+44 (0)161 468 6688
Natalie Cullington, Head of Media & Corporate Affairs
+44 (0)161 468 6688
About Pets At Home
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAFFFIIRIIFIIS
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.